Attix Pharmaceuticals recalls Potassium Phosphate Monobasic pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmac…

Recall date

November 14, 2014

Source

U.S. Food & Drug Administration (FDA) — enforcement report

Recall number

D-851-2015

FDA classification

Class II

Brand / firm

Attix Pharmaceuticals

Sold / distributed

Nationwide to compounding pharmacies and research organizations.

Why it was recalled

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Potassium Phosphate Monobasic pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada